CLINICAL CHEMISTRY LACTATE DEHYDROGENASE 02P56-21

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2017-03-02 for CLINICAL CHEMISTRY LACTATE DEHYDROGENASE 02P56-21 manufactured by Abbott Manufacturing Inc.

Event Text Entries

[68981670] An evaluation is in process. A follow-up report will be submitted when the evaluation is complete.
Patient Sequence No: 1, Text Type: N, H10


[68981671] The customer reports the following results for patient samples tested with the architect clin chem ldh assay: sid l29006814: initial result of 427 u/l with retest at 301 u/l. Sid l290010156: initial result of 407 u/l with restest at 325 u/l. Sid l290033852 : initial result of 304 u/l with retests at 182. 90, 188. 35 and on another analyzer in the lab at 173. 36 and 240. 61 u/l. Sid l290033823: initial result of 317 u/l with retests at 255. 61 and 268 u/l. Sid l290033875: no initial test results provided, but retest result of 200, 220 u/l are documented. Reference is also made to an undisclosed publication the customer referenced, which stated that an ldh decrease in results from approximately 700 u/l to 200 u/l is significant. The customer believes that the higher results are falsely elevated. There is no impact to patient management reported.
Patient Sequence No: 1, Text Type: D, B5


[71757696] A review of complaint tracking and trending metrics was performed and identified no adverse trends in conjunction with the complaint issue currently under evaluation. No returns were made available from the customer site for this evaluation. The clin chem lactate dehydrogenase (ldh) assay package insert and the architect system operations manual provide information to address the current customer issue. Based on the available information from the customer site and from the results of this evaluation, there is evidence to reasonably suggest a product malfunction occurred. However, no systemic issue or product deficiency was identified.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1628664-2017-00051
MDR Report Key6371938
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2017-03-02
Date of Report2017-03-29
Date of Event2017-02-06
Date Mfgr Received2017-03-28
Device Manufacturer Date2016-10-10
Date Added to Maude2017-03-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1ABBOTT MANUFACTURING INC
Manufacturer Street1921 HURD DRIVE
Manufacturer CityIRVING TX 75038
Manufacturer CountryUS
Manufacturer Postal Code75038
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCLINICAL CHEMISTRY LACTATE DEHYDROGENASE
Generic NameLACTATE DEHYDROGENASE
Product CodeCFJ
Date Received2017-03-02
Catalog Number02P56-21
Lot Number89174UN16
Device Expiration Date2017-08-02
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT MANUFACTURING INC
Manufacturer Address1921 HURD DRIVE IRVING TX 75038 US 75038


Patients

Patient NumberTreatmentOutcomeDate
10 2017-03-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.